← Back to Clinical Trials
Recruiting NCT07631585

NCT07631585 Patient AI Trust Dynamics Before and After Orthopedic Consultation (ORTHO-OP-GPT)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07631585
Status Recruiting
Phase
Sponsor Utku Gürhan
Condition Patient Health Information Seeking Behavior
Study Type OBSERVATIONAL
Enrollment 180 participants
Start Date 2026-06
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 180 participants in total. It began in 2026-06 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Patients increasingly consult artificial intelligence (AI) chatbots such as ChatGPT for health information before clinical visits, yet the impact of an actual orthopedic consultation on patient trust in AI-derived information remains unknown. This prospective longitudinal observational study quantifies how a single orthopedic outpatient consultation modifies patient trust in AI chatbots, the concordance between AI-derived and physician-delivered information, and patient anxiety, using a paired pre-post survey design supplemented by a matched physician-side assessment. Adult patients (18 years and older) presenting to two orthopedic outpatient clinics in Cyprus complete a brief pre-consultation questionnaire (T0) capturing demographics, AI use patterns, prior AI consultation regarding the current complaint, baseline trust, expectations, and anxiety. Immediately after their consultation they complete a second questionnaire (T1) assessing concordance with physician advice, trust change, consultation facilitation, post-consultation anxiety, and future intention. The consulting physician completes a brief 30-second post-visit form capturing whether AI was discussed, the medical accuracy of AI-derived information conveyed by the patient, and the effect of the AI discussion on consultation duration. The primary outcomes are the paired within-patient change in AI trust between T0 and T1 and physician-patient concordance on AI versus physician advice. Target enrollment is 180 to obtain 150 paired completed assessments.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older * Presenting to an orthopedic outpatient clinic for any consultation * Able to read and respond to a Turkish-language questionnaire * Provides informed consent Exclusion Criteria: * Inability to complete a self-report questionnaire (e.g., severe cognitive impairment, language barrier) * Re-presentation within the same recruitment window (each patient is enrolled only once) * Refusal of consent for either T0 or T1

Contact & Investigator

Central Contact

Utku Gurhan, MD

✉ utkugrhn@gmail.com

📞 +90 539 112 6898

Principal Investigator

Utku Gurhan, MD

PRINCIPAL INVESTIGATOR

University of Kyrenia

Frequently Asked Questions

Who can join the NCT07631585 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Patient Health Information Seeking Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07631585 currently recruiting?

Yes, NCT07631585 is actively recruiting participants. Contact the research team at utkugrhn@gmail.com for enrollment information.

Where is the NCT07631585 trial being conducted?

This trial is being conducted at Kyrenia, Cyprus, Nicosia, Cyprus.

Who is sponsoring the NCT07631585 clinical trial?

NCT07631585 is sponsored by Utku Gürhan. The principal investigator is Utku Gurhan, MD at University of Kyrenia. The trial plans to enroll 180 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology